Our Mission
The opioid epidemic continues to impact communities across the country, with profound effects on Maryland. More than 1,300 opioid-related deaths were reported in Maryland in 2025. With a statewide leadership role in responding to this crisis, the Division of Addiction Research and Treatment at the University of Maryland School of Medicine has developed and implemented a number of clinical initiatives, specialized programs and community collaborations.
Working with multiple organizations and state agencies, the Division of Addiction Research and Treatment serves as a leader in addressing the current crisis by improving treatment and outcomes for individuals with opioid use disorder.
The Division of Addiction Research and Treatment is nationally recognized for its decades-long, pioneering work in driving evidence-based approaches to substance use disorder treatment. This effort is evident on several fronts and includes both innovative clinical treatment approaches, such as telemedicine and education for medical students and advanced trainees.
The successful outcomes of our programs represent a level of excellence demonstrated by the awards of longstanding clinical service and basic research grants, as well as an established presence on multiple committees and task forces commissioned to deal with Maryland's opioid and heroin problem.
Our faculty continue to testify to legislators in Annapolis about a variety of addiction-related issues, including medication-assisted treatment, drug overdose and naloxone availability, in addition to needle/syringe exchanges and safe consumption spaces.
Division Director
Eric Weintraub, MD
Professor, Psychiatry
Associate Director, Kahlert Institute for Addiction Medicine
Contact Us
Octavia Griffin
Administrative Specialist
Division of Addiction Research and Treatment
Email: ogriffin@som.umaryland.edu